Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.58 USD | +3.62% | +0.23% | -36.68% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.68% | 789M | |
-1.12% | 103B | |
+5.65% | 101B | |
+5.36% | 23.07B | |
-11.58% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.41% | 16.94B | |
+7.10% | 14.07B | |
+38.32% | 12.35B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Sage Therapeutics, Inc. - Special Call